Sheldon Koenig

Chief Executive Officer at ESPERION THERAPEUTICS, INC.

Net worth: 2 M $ as of 2024-04-29

58 year

Health Technology

Consumer Services

Active connections

Name	Gender	Age	Linked companies	Collaboration
Robert Davis	M	57	MERCK & CO., INC.	10 years
Pamela Conley	M	-	Nuvig Therapeutics, Inc. Nuvig Therapeutics, Inc. BiotechnologyHealth Technology Nuvig Therapeutics, Inc. is a company that is focused on developing innovative therapies for patients with chronic autoimmune diseases. The company is based in Redwood City, CA. The company's goal is to induce natural mechanisms that restore immune homeostasis and rebalance immune function following inflammation. Nuvig Therapeutics was founded by Greg Coffey, Jeffrey V. Ravetch, Sheldon L. Koenig, Pamela B. Conley, Joanne M. Quan. Julie Anne Smith has been the CEO of the company since 2023.	-
Stephen Rocamboli	M	52	ESPERION THERAPEUTICS, INC.	2 years
Benjamin Looker	M	42	ESPERION THERAPEUTICS, INC.	2 years
Dalton Smart	M	58	MERCK & CO., INC.	15 years
Chirfi Guindo	M	58	MERCK & CO., INC.	13 years
J. Carroll	M	74	ESPERION THERAPEUTICS, INC.	2 years
Marianne Andreach	F	-	ESPERION THERAPEUTICS, INC.	-
Julie Smith	F	53	Nuvig Therapeutics, Inc. Nuvig Therapeutics, Inc. BiotechnologyHealth Technology Nuvig Therapeutics, Inc. is a company that is focused on developing innovative therapies for patients with chronic autoimmune diseases. The company is based in Redwood City, CA. The company's goal is to induce natural mechanisms that restore immune homeostasis and rebalance immune function following inflammation. Nuvig Therapeutics was founded by Greg Coffey, Jeffrey V. Ravetch, Sheldon L. Koenig, Pamela B. Conley, Joanne M. Quan. Julie Anne Smith has been the CEO of the company since 2023.	1 years
Benjamin Halladay	M	38	ESPERION THERAPEUTICS, INC.	4 years
Greg Coffey	M	-	Nuvig Therapeutics, Inc. Nuvig Therapeutics, Inc. BiotechnologyHealth Technology Nuvig Therapeutics, Inc. is a company that is focused on developing innovative therapies for patients with chronic autoimmune diseases. The company is based in Redwood City, CA. The company's goal is to induce natural mechanisms that restore immune homeostasis and rebalance immune function following inflammation. Nuvig Therapeutics was founded by Greg Coffey, Jeffrey V. Ravetch, Sheldon L. Koenig, Pamela B. Conley, Joanne M. Quan. Julie Anne Smith has been the CEO of the company since 2023.	-
Tracy Woody	F	54	ESPERION THERAPEUTICS, INC.	5 years
Eric Warren	M	76	ESPERION THERAPEUTICS, INC.	3 years
Jay Shepard	M	66	ESPERION THERAPEUTICS, INC.	6 years
Nicole Vitullo	F	66	ESPERION THERAPEUTICS, INC.	16 years
Antonio Gotto	M	88	ESPERION THERAPEUTICS, INC.	10 years
Alan Fuhrman	M	67	ESPERION THERAPEUTICS, INC.	4 years
Remsberg Heidi	F	-	Nuvig Therapeutics, Inc. Nuvig Therapeutics, Inc. BiotechnologyHealth Technology Nuvig Therapeutics, Inc. is a company that is focused on developing innovative therapies for patients with chronic autoimmune diseases. The company is based in Redwood City, CA. The company's goal is to induce natural mechanisms that restore immune homeostasis and rebalance immune function following inflammation. Nuvig Therapeutics was founded by Greg Coffey, Jeffrey V. Ravetch, Sheldon L. Koenig, Pamela B. Conley, Joanne M. Quan. Julie Anne Smith has been the CEO of the company since 2023.	2 years
Andre Musto	M	-	MERCK & CO., INC.	10 years
Carol Bowden	F	-	MERCK & CO., INC.	10 years
Allan Gabor	M	-	MERCK & CO., INC.	11 years
JoAnne Foody	M	59	ESPERION THERAPEUTICS, INC.	3 years
Hannah Chang	M	-	Nuvig Therapeutics, Inc. Nuvig Therapeutics, Inc. BiotechnologyHealth Technology Nuvig Therapeutics, Inc. is a company that is focused on developing innovative therapies for patients with chronic autoimmune diseases. The company is based in Redwood City, CA. The company's goal is to induce natural mechanisms that restore immune homeostasis and rebalance immune function following inflammation. Nuvig Therapeutics was founded by Greg Coffey, Jeffrey V. Ravetch, Sheldon L. Koenig, Pamela B. Conley, Joanne M. Quan. Julie Anne Smith has been the CEO of the company since 2023.	-
Alexis Callahan	M	-	ESPERION THERAPEUTICS, INC.	-
Kenneth Harrison	M	44	Nuvig Therapeutics, Inc. Nuvig Therapeutics, Inc. BiotechnologyHealth Technology Nuvig Therapeutics, Inc. is a company that is focused on developing innovative therapies for patients with chronic autoimmune diseases. The company is based in Redwood City, CA. The company's goal is to induce natural mechanisms that restore immune homeostasis and rebalance immune function following inflammation. Nuvig Therapeutics was founded by Greg Coffey, Jeffrey V. Ravetch, Sheldon L. Koenig, Pamela B. Conley, Joanne M. Quan. Julie Anne Smith has been the CEO of the company since 2023.	-
Denise Williams	F	-	MERCK & CO., INC.	15 years
Pamela Eisele	F	-	MERCK & CO., INC.	15 years
Sanat Chattopadhyay	M	-	MERCK & CO., INC.	15 years
Richard DeLuca	M	61	MERCK & CO., INC.	13 years
Glenn Brame	M	67	ESPERION THERAPEUTICS, INC.	1 years
Seth Fischer	M	68	ESPERION THERAPEUTICS, INC.	3 years
Betty Jean	F	-	ESPERION THERAPEUTICS, INC.	3 years

Connections Chart

Multi-company connection

Former connections

Name	Gender	Age	Linked companies	Collaboration
Mardi Dier	F	60	PORTOLA PHARMACEUTICALS, INC.	14 years
J. Garland	M	55	PORTOLA PHARMACEUTICALS, INC.	2 years
Jeffrey Berkowitz	M	58	MERCK & CO., INC. ESPERION THERAPEUTICS, INC.	8 years
Fred Hassan	M	78	MERCK & CO., INC.	6 years
Richard Clark	M	77	MERCK & CO., INC.	6 years
Tim Mayleben	M	63	ESPERION THERAPEUTICS, INC.	11 years
Carlos Eduardo Represas de Almeida	M	78	MERCK & CO., INC.	-
Julie Gerberding	M	69	MERCK & CO., INC.	-
Rick Bartram	M	63	ESPERION THERAPEUTICS, INC.	9 years
Michael Nally	M	48	MERCK & CO., INC.	10 years
Jean-Marie Canan	M	68	MERCK & CO., INC.	5 years
John Curnutte	M	72	PORTOLA PHARMACEUTICALS, INC.	8 years
Larry G. Edwards	M	52	MERCK & CO., INC.	15 years
Daniel Janney	M	58	ESPERION THERAPEUTICS, INC.	9 years
John Moriarty	M	56	PORTOLA PHARMACEUTICALS, INC.	2 years
Robert Iannone	M	57	MERCK & CO., INC.	6 years
Laura Brege	F	66	PORTOLA PHARMACEUTICALS, INC.	5 years
Laura Sepp-Lorenzino	M	63	MERCK & CO., INC.	15 years
Hollings Renton	M	77	PORTOLA PHARMACEUTICALS, INC.	10 years
William N. Kelley	M	84	MERCK & CO., INC.	-
Thomas Robert Cech	M	76	MERCK & CO., INC.	-
Ted Love	M	65	PORTOLA PHARMACEUTICALS, INC.	1 years
Thomas Shenk	M	77	MERCK & CO., INC.	11 years
Caroline Dorsa	F	64	MERCK & CO., INC.	22 years
Mark E. McGovern	M	70	ESPERION THERAPEUTICS, INC.	8 years
Harry R. Jacobson	M	76	MERCK & CO., INC.	3 years
Henry Ward Wolff	M	75	PORTOLA PHARMACEUTICALS, INC.	13 years
Steven Goldstone	M	78	MERCK & CO., INC.	6 years
Barbara Yanni	F	69	MERCK & CO., INC.	13 years
Jacob Harel	M	69	MERCK & CO., INC.	13 years
Barry Gertz	M	72	MERCK & CO., INC.	28 years
Mark Shearman	M	62	MERCK & CO., INC.	3 years
Rupert Vessey	M	59	MERCK & CO., INC.	-
Maude Tessier	M	46	MERCK & CO., INC.	6 years
Lu Amy Sun	M	67	MERCK & CO., INC.	7 years
Juan Camilo Arjona Ferreira	M	54	MERCK & CO., INC.	12 years
Hugo Wahnish	M	-	MERCK & CO., INC.	18 years
Ernesto Aycardi	M	61	MERCK & CO., INC.	11 years
Yao Lee	M	54	MERCK & CO., INC.	3 years
James Swanson	M	58	MERCK & CO., INC.	8 years
Robert Plenge	M	53	MERCK & CO., INC.	4 years
Jens Renstrup	M	59	MERCK & CO., INC.	8 years
Yan Li	F	50	MERCK & CO., INC.	4 years
Stijn Michiel Ehren	M	-	MERCK & CO., INC.	-
Rita Karachun	F	63	MERCK & CO., INC.	14 years
Lawrence D. Senour	M	59	MERCK & CO., INC.	-
David Mauro	M	59	MERCK & CO., INC.	7 years
Peter Kellogg	M	67	MERCK & CO., INC.	7 years
Dennis Erb	M	-	MERCK & CO., INC.	-
Thomas J. Ouellette	M	-	MERCK & CO., INC.	16 years
Michael Holston	M	61	MERCK & CO., INC.	6 years
John Z. Sullivan-Bólyai	M	76	MERCK & CO., INC.	11 years
Christopher Garland	M	-	MERCK & CO., INC.	-
Piotr Bobrowicz	M	-	MERCK & CO., INC.	-
Peter Honig	M	67	MERCK & CO., INC.	7 years
David A. Esposito	M	55	MERCK & CO., INC.	13 years
Barry Goldstein	M	-	MERCK & CO., INC.	5 years
Aaron Dent	M	-	MERCK & CO., INC.	6 years
Eric Schadt	M	59	MERCK & CO., INC.	8 years
Glenn Williams	M	-	MERCK & CO., INC.	10 years
Pernilla Sandwall	F	61	MERCK & CO., INC.	8 years
Geralyn S. Ritter	F	-	MERCK & CO., INC.	8 years
Graham Lumsden	M	64	MERCK & CO., INC.	26 years
James F. Fuqua	M	-	MERCK & CO., INC.	31 years
Nancy Thornberry	F	67	MERCK & CO., INC.	9 years
Karen Ling	F	60	MERCK & CO., INC.	6 years
Arnaub Chatterjee	M	-	MERCK & CO., INC.	5 years

Statistics

Country	Connections	% of total
United States	99	100.00%

Age of Connections

Active

Past

Male

Female

Members of the board

Executives

Origin of connections